(Information sent by the signatory company)
– ArisGlobal signs agreement to acquire Amplexor Life Sciences, creating the most comprehensive regulatory SaaS platform in the industry
The complementary combination of these two leading regulatory firms provides an unmatched offering to the global marketplace.
MIAMI and NOVO MESTO, Slovenia, March 1, 2023 /PRNewswire/ — ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its comprehensive LifeSphere® technology platform, today announces the acquisition of Amplexor Life Sciences (LS), a global provider of safety, quality and regulatory software solutions, served and trusted by pharmaceutical, biotechnology and medical device companies.
The integration of regulatory product lines will bring a different set of benefits for clients. LifeSphere users now get access to enhanced posting and tagging capabilities; in addition to a robust Amplexor LS Quality Management System (QMS). Amplexor LS regulatory customers can now connect to even broader functionality through ArisGlobal’s market-leading LifeSphere platform, including access to state-of-the-art clinical, medical and security solutions.
This ecosystem of combined products offers a new opportunity for life sciences companies, as it brings together the best solutions to form a cohesive solution that meets the regulatory needs of customers. It also represents many years of industry experience, software innovation, and customer excellence from ArisGlobal and Amplexor Life Sciences. This move will accelerate both companies’ roadmaps and increase efficiency in bringing new therapies to market.
“For many years, ArisGlobal has focused on building a regulatory platform that provides a comprehensive, market-leading suite of products and streamlines processes that support collaboration among distributed teams while adhering to extensive and evolving global regulatory requirements,” explained Mike Gordon, CEO at ArisGlobal. “By combining our core functionalities, we are elevating our end-to-end regulatory capabilities to enhance our customer journey.”
“Amplexor Life Sciences has always sought to provide its customers with operational excellence in global compliance, and this new chapter of our products within the LifeSphere regulatory platform will continue to do so,” said Elvis Paćelat, executive vice president of Amplexor LS. “We are excited to join forces with ArisGlobal, which has been an innovator in the life sciences space for several decades, to bring to market a full range of products designed to make regulatory processes a connected, data-driven experience. cloud and compatible”.
“The vision and goals of ArisGlobal and Amplexor LS are aligned,” said Jim Hilferty, Assistant Vice President and Head of Regulatory Affairs at ArisGlobal. “We are confident that bringing our organizations together will serve as a catalyst for innovation for the benefit of life sciences and will enable us to offer the most intelligent, connected and comprehensive platform available to the regulatory community.”
Both companies have been supporting RD processes through technology for decades, with offices throughout Europe, the United States, India and the APAC region.
The integration is subject to the usual government approvals which are expected to be completed within the next 60 days. More information will be available on the combined solution.
For more information, visit arisglobal.com and amplexorlifesciences.com.
About ArisGlobal
About Amplexor Life Sciences: Amplexor Life Sciences is a global provider of safety, quality and regulatory software solutions, serving and trusted by pharmaceutical, biotechnology and medical device companies for more than 30 years. Its holistic suite of life science solutions help life science organizations to be efficient with product launches and new market penetration quickly, while ensuring quality, efficacy and safety through the Comprehensive support for product lifecycle processes, data and content management.
Logo – https://mma.prnewswire.com/media/1510670…
View original content: https://www.prnewswire.com/news-releases/arisglobal-firma-un-acuerdo-para-adquirir-amplexor-life-sciences-301758911.html
